Machine Learning for Predicting Hepatitis C Virus Therapy Outcomes: HCV in Egypt - Couverture souple

Said, Marwa ; El Hefnawi, Mahmoud ; Abdalla, Mahmoud

9783330059641: Machine Learning for Predicting Hepatitis C Virus Therapy Outcomes: HCV in Egypt

Couverture souple

ISBN 10 : 3330059648 ISBN 13 : 9783330059641

Editeur : LAP LAMBERT Academic Publishing, 2017

Afficher les exemplaires de cette �dition comportant l'ISBN

0 D'occasion

9 Neuf

De EUR 49,90

Although the current scientific revolution and the great improving of the health care systems, hepatitis C virus (HCV) continues to be a major health risk in both developed and developing countries and is considered one of the most important causes of chronic liver disease. It accounts for about 15% of acute viral hepatitis, 60% to 70% of chronic hepatitis C(CHC) and up to 50% of cirrhosis, end-stage liver disease and liver cancer. An estimated 150-200 million people worldwide are infected with hepatitis C. Unfortunately,there are a few published simulation models related to HCV problem.All attempts depending on one mathematical model that describes the virologic infections published by Alan Perelson at 1999. After that, many researchers applied this model on studying hepatitis C dynamics. Comparatively higher rate of sustained virologic response(SVR)which defined as undetectable HCV ribonucleic acid(RNA)and end of treatment response(ETR) observed more pronounced in patients treated with pegylated interferon (Peg-IFN) and ribavirin(RBV) than standard combination treatment. Patients with CHC often stop subsuming the treatment because of the high cost and related unfavorable effects.

Les informations fournies dans la section � Synopsis � peuvent faire r�f�rence � une autre �dition de ce titre.

� propos de l'auteur

Marwa S. Hassan, M.SC: studied in bioinformatics team at national research center and Zagazig University, interested in the issues of my country, headed by virus C problem which is described in this book. Assistant researcher at the National Research Center, Cairo.

Les informations fournies dans la section � A propos du livre � peuvent faire r�f�rence � une autre �dition de ce titre.

�diteur: LAP LAMBERT Academic Publishing
Date d'�dition: 2017
Langue: anglais
ISBN 10: 3330059648
ISBN 13: 9783330059641
Reliure: Broch�
Nombre de pages: 120
Coordonn�es du fabricant: non disponible
Personne responsable: KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne

R�sultats de recherche pour Machine Learning for Predicting Hepatitis C Virus Therapy...

Image fournie par le vendeur

Machine Learning for Predicting Hepatitis C Virus Therapy Outcomes

Marwa Said

Edit� par LAP LAMBERT Academic Publishing Mrz 2017, 2017

ISBN 10 : 3330059648 ISBN 13 : 9783330059641

Neuf Taschenbuch

impression � la demande

Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Although the current scientific revolution and the great improving of the health care systems, hepatitis C virus (HCV) continues to be a major health risk in both developed and developing countries and is considered one of the most important causes of chronic liver disease. It accounts for about 15% of acute viral hepatitis, 60% to 70% of chronic hepatitis C(CHC) and up to 50% of cirrhosis, end-stage liver disease and liver cancer. An estimated 150-200 million people worldwide are infected with hepatitis C. Unfortunately,there are a few published simulation models related to HCV problem.All attempts depending on one mathematical model that describes the virologic infections published by Alan Perelson at 1999. After that, many researchers applied this model on studying hepatitis C dynamics. Comparatively higher rate of sustained virologic response(SVR)which defined as undetectable HCV ribonucleic acid(RNA)and end of treatment response(ETR) observed more pronounced in patients treated with pegylated interferon (Peg-IFN) and ribavirin(RBV) than standard combination treatment. Patients with CHC often stop subsuming the treatment because of the high cost and related unfavorable effects. 120 pp. Englisch. N� de r�f. du vendeur 9783330059641

Contacter le vendeur

Acheter neuf

EUR 49,90

Exp�dition �EUR 23
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 2 disponible(s)

Ajouter au panier

Image d'archives

Machine Learning for Predicting Hepatitis C Virus Therapy Outcomes: HCV in Egypt

Said, Marwa; El Hefnawi, Mahmoud; Abdalla, Mahmoud

Edit� par LAP LAMBERT Academic Publishing, 2017

ISBN 10 : 3330059648 ISBN 13 : 9783330059641

Neuf Couverture souple

Vendeur : Books Puddle, New York, NY, Etats-Unis

�valuation du vendeur 4 sur 5 �toiles

Etat : New. N� de r�f. du vendeur 26394749851

Contacter le vendeur

Acheter neuf

EUR 78,69

Exp�dition �EUR 3,45
Exp�dition nationale�: Etats-Unis

Quantit� disponible : 4 disponible(s)

Ajouter au panier

Image d'archives

Machine Learning for Predicting Hepatitis C Virus Therapy Outcomes: HCV in Egypt

Said, Marwa; El Hefnawi, Mahmoud; Abdalla, Mahmoud

Edit� par LAP LAMBERT Academic Publishing, 2017

ISBN 10 : 3330059648 ISBN 13 : 9783330059641

Neuf Couverture souple

impression � la demande

Vendeur : Majestic Books, Hounslow, Royaume-Uni

�valuation du vendeur 4 sur 5 �toiles

Etat : New. Print on Demand. N� de r�f. du vendeur 401659972

Contacter le vendeur

Acheter neuf

EUR 78,83

Exp�dition �EUR 7,59
Exp�dition depuis Royaume-Uni vers Etats-Unis

Quantit� disponible : 4 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Machine Learning for Predicting Hepatitis C Virus Therapy Outcomes

Marwa Said|Mahmoud El Hefnawi|Mahmoud Abdalla

Edit� par LAP LAMBERT Academic Publishing, 2017

ISBN 10 : 3330059648 ISBN 13 : 9783330059641

Neuf Couverture souple

impression � la demande

Vendeur : moluna, Greven, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Said MarwaMarwa S. Hassan, M.SC: studied in bioinformatics team at national research center and Zagazig University, interested in the issues of my country, headed by virus C problem which is described in this book. Assistant research. N� de r�f. du vendeur 151235379

Contacter le vendeur

Acheter neuf

EUR 41,71

Exp�dition �EUR 48,99
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : Plus de 20 disponibles

Ajouter au panier

Image d'archives

Machine Learning for Predicting Hepatitis C Virus Therapy Outcomes: HCV in Egypt

Said, Marwa; El Hefnawi, Mahmoud; Abdalla, Mahmoud

Edit� par LAP LAMBERT Academic Publishing, 2017

ISBN 10 : 3330059648 ISBN 13 : 9783330059641

Neuf Couverture souple

impression � la demande

Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne

�valuation du vendeur 4 sur 5 �toiles

Etat : New. PRINT ON DEMAND. N� de r�f. du vendeur 18394749841

Contacter le vendeur

Acheter neuf

EUR 81,03

Exp�dition �EUR 9,95
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 4 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Machine Learning for Predicting Hepatitis C Virus Therapy Outcomes

Marwa Said

Edit� par LAP LAMBERT Academic Publishing M�r 2017, 2017

ISBN 10 : 3330059648 ISBN 13 : 9783330059641

Neuf Taschenbuch

impression � la demande

Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Although the current scientific revolution and the great improving of the health care systems, hepatitis C virus (HCV) continues to be a major health risk in both developed and developing countries and is considered one of the most important causes of chronic liver disease. It accounts for about 15% of acute viral hepatitis, 60% to 70% of chronic hepatitis C(CHC) and up to 50% of cirrhosis, end-stage liver disease and liver cancer. An estimated 150-200 million people worldwide are infected with hepatitis C. Unfortunately,there are a few published simulation models related to HCV problem.All attempts depending on one mathematical model that describes the virologic infections published by Alan Perelson at 1999. After that, many researchers applied this model on studying hepatitis C dynamics. Comparatively higher rate of sustained virologic response(SVR)which defined as undetectable HCV ribonucleic acid(RNA)and end of treatment response(ETR) observed more pronounced in patients treated with pegylated interferon (Peg-IFN) and ribavirin(RBV) than standard combination treatment. Patients with CHC often stop subsuming the treatment because of the high cost and related unfavorable effects.VDM Verlag, Dudweiler Landstra�e 99, 66123 Saarbr�cken 120 pp. Englisch. N� de r�f. du vendeur 9783330059641

Contacter le vendeur

Acheter neuf

EUR 49,90

Exp�dition �EUR 60
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Machine Learning for Predicting Hepatitis C Virus Therapy Outcomes : HCV in Egypt

Mahmoud Abdalla

Edit� par LAP LAMBERT Academic Publishing, 2017

ISBN 10 : 3330059648 ISBN 13 : 9783330059641

Neuf Taschenbuch

impression � la demande

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Although the current scientific revolution and the great improving of the health care systems, hepatitis C virus (HCV) continues to be a major health risk in both developed and developing countries and is considered one of the most important causes of chronic liver disease. It accounts for about 15% of acute viral hepatitis, 60% to 70% of chronic hepatitis C(CHC) and up to 50% of cirrhosis, end-stage liver disease and liver cancer. An estimated 150-200 million people worldwide are infected with hepatitis C. Unfortunately,there are a few published simulation models related to HCV problem.All attempts depending on one mathematical model that describes the virologic infections published by Alan Perelson at 1999. After that, many researchers applied this model on studying hepatitis C dynamics. Comparatively higher rate of sustained virologic response(SVR)which defined as undetectable HCV ribonucleic acid(RNA)and end of treatment response(ETR) observed more pronounced in patients treated with pegylated interferon (Peg-IFN) and ribavirin(RBV) than standard combination treatment. Patients with CHC often stop subsuming the treatment because of the high cost and related unfavorable effects. N� de r�f. du vendeur 9783330059641

Contacter le vendeur